Document Detail

Transurethral injection of bulking agent for treatment of failed mid-urethral sling procedures.
MedLine Citation:
PMID:  20645075     Owner:  NLM     Status:  MEDLINE    
INTRODUCTION AND HYPOTHESIS: We evaluated the efficacy of transurethral injection (TUI) for the treatment of recurrent or persistent stress urinary incontinence after mid-urethral sling (MUS) procedures.
METHODS: A retrospective study was conducted among 23 women who had undergone TUI for failed MUS using bulking agents, Macroplastique® and Durasphere®. The Sandvik questionnaire, Subjective Symptom Visual Analogue Scale (VAS), Incontinence Quality of Life (I-QOL) assessment, and Benefit, Satisfaction, and Willingness to Continue questionnaire were used to evaluate the efficacy of TUI.
RESULTS: The cure rate was 34.8% for a median follow-up of 10 months. Subjective symptom VAS, total, and all domains of I-QOL scores were significantly improved after TUI. Ninety-two percent of the patients reported a benefit and 77% of the patients were satisfied with the treatment.
CONCLUSIONS: TUI for failed MUS demonstrated a low cure rate but high patient satisfaction, and the procedure was minimally invasive with no significant complications.
Ha Na Lee; Young-Suk Lee; Ji-Yeon Han; Jae Yong Jeong; Myung-Soo Choo; Kyu-Sung Lee
Related Documents :
16082725 - Pathogenesis of urethral funneling in women with stress urinary incontinence assessed b...
9283515 - Improvement in inducible ischemia during dobutamine stress echocardiography after trans...
15925085 - Value of preoperative urethral ultrasound in optic internal urethrotomy.
14710075 - Cadaveric fascia lata sling for stress urinary incontinence: a prospective quality-of-l...
8730245 - Treatment of helicobacter pylori infection with low or high dose omeprazole combined wi...
11720675 - A treatment scale for axillary management in breast cancer.
Publication Detail:
Type:  Journal Article     Date:  2010-07-20
Journal Detail:
Title:  International urogynecology journal     Volume:  21     ISSN:  1433-3023     ISO Abbreviation:  Int Urogynecol J     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-10     Completed Date:  2011-03-10     Revised Date:  2011-08-18    
Medline Journal Info:
Nlm Unique ID:  101567041     Medline TA:  Int Urogynecol J     Country:  England    
Other Details:
Languages:  eng     Pagination:  1479-83     Citation Subset:  IM    
Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Combined Modality Therapy
Dimethylpolysiloxanes / administration & dosage,  adverse effects,  therapeutic use*
Equipment Failure*
Follow-Up Studies
Glucans / administration & dosage,  adverse effects,  therapeutic use*
Middle Aged
Patient Satisfaction
Retrospective Studies
Suburethral Slings*
Treatment Outcome
Urinary Incontinence, Stress / therapy*
Zirconium / administration & dosage,  adverse effects,  therapeutic use*
Reg. No./Substance:
0/Dimethylpolysiloxanes; 0/Glucans; 0/durasphere; 63148-62-9/baysilon; 7440-67-7/Zirconium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Contribution of postnatally formed small beta cell aggregates to functional beta cell mass in adult ...
Next Document:  Pelvic pain in urogynaecology. Part I: evaluation, definitions and diagnoses.